GlassScriptPhysician profile
Priscilla Lamberti
NPI 1396447462
$5,138.87
in general payments reported to CMS, 2019-2025
39 companies · $3,945 in 2025
The $3,945 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.88 · 2024: $1,161 · 2025: $3,945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,172 · Long Term Medical Supply Or Device Loan: $698 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,171.99 |
| Long Term Medical Supply Or Device Loan | $697.90 |
| Education | $268.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,089.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $360.78 | 2024-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Daiichi Sankyo INC. | $351.02 | 2024-2025 | Enhertu, Datroway |
| Janssen Biotech, INC. | $318.51 | 2024-2025 | Rybrevant, Carvykti, Darzalex |
| Astrazeneca Pharmaceuticals LP | $282.57 | 2024-2025 | Enhertu, Imfinzi, Lynparza |
| Lilly USA, LLC | $254.51 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Glaxosmithkline, LLC. | $211.00 | 2024-2025 | Ojjaara, Blenrep, Zejula |
| Genzyme Corporation | $205.41 | 2024-2025 | |
| Gilead Sciences, INC. | $199.13 | 2025 | Trodelvy |
| Regeneron Healthcare Solutions, INC. | $193.10 | 2024-2025 | Libtayo |
| Pfizer INC. | $119.41 | 2025 | |
| Legend Biotech USA INC. | $116.31 | 2025 | Carvykti |
| Takeda Pharmaceuticals U.S.A., INC. | $115.12 | 2024-2025 | Alunbrig, Fruzaqla |
| Incyte Corporation | $110.81 | 2024-2025 | Jakafi, Monjuvi, Zynyz |
| Abbvie INC. | $106.65 | 2023-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Lamberti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.